Endometrial carcinoma(EC) patients staged stage Ia or Ib have different operation methods and prognosis. To evaluate the value of enhanced T2*-weighted angiography(ESWAN) in the differential diagnosis between stage Ia and Ib of endometrial carcinoma. In this work, we found it is feasible that ESWAN sequence derived R2* value can be applied in the differential diagnosis between stage Ia and Ib of endometrial carcinoma, which can provide detailed information for clinical treatment.
This abstract and the presentation materials are available to members only; a login is required.